AT1R-AAs are deemed to exert pathogenic effects and have been implicated in various diseases such as metabolic syndrome [23], malignant hypertension [24], unstable angina (UA) [25], renal transplant rejection [26], frailty [27], Alzheimer’s disease [28], and COVID-19 [29–31]. This evidence concerns the gene AGTR1 and COVID-19.